Innovation in neuroscience
Promising new treatments
Stream Neuroscience is revolutionizing treatment of neurological disorders
Our innovative therapies delve deep inside the cell to activate crucial molecular targets and restore brain health. Using our patented drug discovery platform we have uncovered novel therapies with potential to treat patients suffering from:
- Focal Onset Epilepsy
- Generalized Epilepsy
- Developmental and Epileptic Encephalopathies
Focal Onset and Generalized Epilepsy
Epileptic seizures result from disrupted signalling between key brain regions, where an imbalance between excitatory and inhibitory pathways leads to abnormal activity. These seizures may originate in a specific brain area (focal onset) or spread across multiple regions (generalized). Stream Neuroscience is advancing molecular-level therapies designed to correct the underlying signalling imbalances in epilepsy while also addressing associated cognitive and anxiety-related comorbidities.
Developmental and Epileptic Encephalopathies
Developmental and Epileptic Encephalopathies (DEEs) are debilitating neurodevelopmental disorders marked by early-onset, treatment-resistant seizures and significant developmental impairments, often driven by genetic mutations that impair brain function. Stream Neuroscience is creating innovative molecular-level therapies to repair the disrupted biological pathways responsible for seizures and associated neurological challenges in DEE patients.
Stream Neuroscience's Innovative Approach
Most conventional neurology therapies target proteins outside the cell. Stream Neuroscience’s therapies are directed toward molecular targets deep inside brain cells, allowing for regulation of many biological pathways responsible for neurological disease and brain health. Through this evidence-based novel approach Stream Neuroscience is pioneering the next generation of neuroscience therapies.
